# Solid Biosciences Inc.: Form SCHEDULE 13D/A, filed Mar 17, 2026

- Company: [Solid Biosciences Inc.](/companies/sldb.md) (CIK 1707502)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-17
- Accepted by EDGAR: Mar 17, 2026, 18:50 ET
- Period: not reported
- Accession: 0001104659-26-029671
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1707502/000110465926029671/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1707502/000110465926029671/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1707502/000110465926029671/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-029671. Last ingested by Listed: Nov 6, 2026, 17:16 ET. No prices; not investment advice.
